These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 24729124)
1. Deficiency in asparagine synthetase expression in rectal cancers receiving concurrent chemoradiotherapy: negative prognostic impact and therapeutic relevance. Lin CY; Sheu MJ; Li CF; Lee SW; Lin LC; Wang YF; Chen SH Tumour Biol; 2014 Jul; 35(7):6823-30. PubMed ID: 24729124 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of CPS1 is an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy. Lee YY; Li CF; Lin CY; Lee SW; Sheu MJ; Lin LC; Chen TJ; Wu TF; Hsing CH Tumour Biol; 2014 Nov; 35(11):11097-105. PubMed ID: 25099619 [TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy. Li CF; He HL; Wang JY; Huang HY; Wu TF; Hsing CH; Lee SW; Lee HH; Fang JL; Huang WT; Chen SH J Clin Pathol; 2014 Dec; 67(12):1056-61. PubMed ID: 25271212 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of ANXA1 confers independent negative prognostic impact in rectal cancers receiving concurrent chemoradiotherapy. Sheu MJ; Li CF; Lin CY; Lee SW; Lin LC; Chen TJ; Ma LJ Tumour Biol; 2014 Aug; 35(8):7755-63. PubMed ID: 24810927 [TBL] [Abstract][Full Text] [Related]
5. High chloride channel accessory 1 expression predicts poor prognoses in patients with rectal cancer receiving chemoradiotherapy. Chen TJ; He HL; Shiue YL; Yang CC; Lin LC; Tian YF; Chen SH Int J Med Sci; 2018; 15(11):1171-1178. PubMed ID: 30123054 [No Abstract] [Full Text] [Related]
6. High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy. Lin CY; Hsieh PL; Chou CL; Yang CC; Lee SW; Tian YF; Shiue YL; Li WS Oncology; 2020; 98(8):549-557. PubMed ID: 32408308 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy. Lee YY; Wei YC; Tian YF; Sun DP; Sheu MJ; Yang CC; Lin LC; Lin CY; Hsing CH; Li WS; Li CF; Hsieh PL; Lin CY J Cancer; 2017; 8(8):1330-1337. PubMed ID: 28638446 [No Abstract] [Full Text] [Related]
8. Overexpression of REG4 confers an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy. He HL; Lee YE; Shiue YL; Lee SW; Lin LC; Chen TJ; Wu TF; Hsing CH; Huang HY; Wang JY; Li CF J Surg Oncol; 2014 Dec; 110(8):1002-10. PubMed ID: 25155043 [TBL] [Abstract][Full Text] [Related]
9. The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapy. Lee YE; He HL; Shiue YL; Lee SW; Lin LC; Wu TF; Chang IW; Lee HH; Li CF Tumour Biol; 2015 Sep; 36(10):7675-83. PubMed ID: 25929810 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of DNAJC12 predicts poor response to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer. He HL; Lee YE; Chen HP; Hsing CH; Chang IW; Shiue YL; Lee SW; Hsu CT; Lin LC; Wu TF; Li CF Exp Mol Pathol; 2015 Jun; 98(3):338-45. PubMed ID: 25805104 [TBL] [Abstract][Full Text] [Related]
11. High SPINK4 Expression Predicts Poor Outcomes among Rectal Cancer Patients Receiving CCRT. Chen TJ; Tian YF; Chou CL; Chan TC; He HL; Li WS; Tsai HH; Li CF; Lai HY Curr Oncol; 2021 Jun; 28(4):2373-2384. PubMed ID: 34202399 [TBL] [Abstract][Full Text] [Related]
12. SERPINB5 Expression: Association with CCRT Response and Prognostic Value in Rectal Cancer. Chang IW; Liu KW; Ragunanan M; He HL; Shiue YL; Yu SC Int J Med Sci; 2018; 15(4):376-384. PubMed ID: 29511373 [No Abstract] [Full Text] [Related]
13. Low BRCA2 expression predicts poor prognoses in patients with rectal cancer receiving chemoradiotherapy. Sheu MJ; Chou CL; Yang CC; Lee SW; Tian YF; Lin CY; Hsiao SY; Chen SH; Huang WT Pathol Res Pract; 2020 May; 216(5):152922. PubMed ID: 32249003 [TBL] [Abstract][Full Text] [Related]
14. PLA2G2A overexpression is associated with poor therapeutic response and inferior outcome in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy. He HL; Lee YE; Shiue YL; Lee SW; Lin LC; Chen TJ; Wu TF; Li CF Histopathology; 2015 Jun; 66(7):991-1002. PubMed ID: 25393083 [TBL] [Abstract][Full Text] [Related]
15. High SLC28A2 expression endows an inferior survival for rectal cancer patients managed by neoadjuvant CCRT. Chen HP; Chen CI; Liu KW; Chen TJ; Tian YF; Kuo YH; Li WS; Tsai HH; Wu LC; Yeh CF; Li CF; Chou CL; Lai HY Pathol Res Pract; 2022 Nov; 239():154158. PubMed ID: 36244249 [TBL] [Abstract][Full Text] [Related]
16. DPYD, TYMS, TYMP, TK1, and TK2 genetic expressions as response markers in locally advanced rectal cancer patients treated with fluoropyrimidine-based chemoradiotherapy. Huang MY; Wu CH; Huang CM; Chung FY; Huang CW; Tsai HL; Chen CF; Lin SR; Wang JY Biomed Res Int; 2013; 2013():931028. PubMed ID: 24455740 [TBL] [Abstract][Full Text] [Related]
17. Role of autophagy-related protein expression in patients with rectal cancer treated with neoadjuvant chemoradiotherapy. Shim BY; Sun S; Won HS; Lee MA; Hong SU; Jung JH; Cho HM; Ko YH BMC Cancer; 2016 Mar; 16():207. PubMed ID: 26965179 [TBL] [Abstract][Full Text] [Related]
18. REG3A overexpression functions as a negative predictive and prognostic biomarker in rectal cancer patients receiving CCRT. Li WS; Chen TJ; Lee SW; Yang CC; Tian YF; Kuo YH; Tsai HH; Wu LC; Yeh CF; Shiue YL; Chou CL; Lai HY Histol Histopathol; 2024 Jan; 39(1):91-104. PubMed ID: 37042618 [TBL] [Abstract][Full Text] [Related]
19. Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma. Zhang B; Dong LW; Tan YX; Zhang J; Pan YF; Yang C; Li MH; Ding ZW; Liu LJ; Jiang TY; Yang JH; Wang HY Br J Cancer; 2013 Jul; 109(1):14-23. PubMed ID: 23764751 [TBL] [Abstract][Full Text] [Related]
20. BMI1-KLF4 axis deficiency improves responses to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer. Hsu YC; Luo CW; Huang WL; Wu CC; Chou CL; Chen CI; Chang SJ; Chai CY; Wang HC; Chen TY; Li CF; Pan MR Radiother Oncol; 2020 Aug; 149():249-258. PubMed ID: 32592893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]